Involvement of Fc receptors in disorders of the central nervous system

NeuroMolecular Medicine

Volumn 12, Issue 2, 2010, Pages 164-178

  Okun, Eitan ^a   Mattson, Mark P ^a   Arumugam, Thiruma V ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alzheimer's disease; CNS; Fc receptors; Innate immunity; Ischemic stroke; Neurons

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID PRECURSOR PROTEIN; CD16 ANTIGEN; CELL SURFACE RECEPTOR; FC ALPHA RECEPTOR I; FC DELTA RECEPTOR; FC EPSILON RECEPTOR I; FC EPSILON RECEPTOR II; FC MU RECEPTOR; FC RECEPTOR; FC RECEPTOR I; FC RECEPTOR IIA; FC RECEPTOR IIB; FC RECEPTOR IV; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIGEN BINDING; ASTROCYTE; BRAIN ISCHEMIA; CYTOKINE PRODUCTION; DEGRANULATION; HUMAN; IMMUNOCOMPETENT CELL; INFECTION RESISTANCE; LYMPHOCYTE; MACROPHAGE; MAST CELL; MICROGLIA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; TISSUE INJURY;

ALZHEIMER DISEASE; ASTROCYTES; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MACROPHAGES; MAST CELLS; MICROGLIA; NEURONS; OLIGODENDROGLIA; RECEPTORS, FC; SIGNAL TRANSDUCTION; STROKE;

EID: 77956393132     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8099-5     Document Type: Review

References (162)

1. Abramson, J., & Pecht, I. (2007). Regulation of the mast cell response to the type 1 Fc epsilon receptor. Immunological Reviews, 217, 231-254.
2. Akilesh, S., et al. (2008). Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proceedings of the National Academy of Sciences of the United States ofAmerica, 105, 967-972.
3. Akiyama, H., et al. (2000). Cell mediators of inflammation in the Alzheimer disease brain. Alzheimer Disease and Associated Disorders, 14, S47-S53.
4. Alliot, F., et al. (1999). Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Research. Developmental Brain Research, 117, 145-152.
5. Amir-Moazami, O., et al. (2008). Phospholipid scramblase 1 modulates a selected set of IgE receptor-mediated mast cell responses through LAT-dependent pathway. The Journal of Biological Chemistry, 283, 25514-25523.
6. Andersson, J., et al. (2005). Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.Clinical And Experimental Medicine, 5, 135-140.
7. Andoh, T., & Kuraishi, Y. (2004a). Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I.FASEB Journal, 18, 182-184.
8. Andoh, T., & Kuraishi, Y. (2004b). Expression of Fc epsilon receptor I on primary sensory neurons in mice. Neuroreport, 15, 2029-2031.
9. Appel, S., et al. (1992). Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs. Annals of Neurology, 32, 494-501.
10. Arumugam, T. V., et al. (2005). Stroke and T-cells. Neuromolecular Medicine, 7, 229-242.
11. Arumugam, T. V., et al. (2006). Gamma secretase-mediated notch signaling worsens brain damage and functional outcome in ischemic stroke. Nature Medicine, 12, 621-623.
12. Arumugam, T. V., et al. (2007). Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proceedings of the National Academy of Sciences of the United States of America, 104, 14104-14109.
13. Arumugam, T. V., et al. (2009). Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience, 158, 1074-1089.
14. Bacskai, B. J., et al. (2002). Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.Journal of Neuroscience, 22, 7873-7878.
15. Baerenwaldt, A., & Nimmerjahn, F. (2008). Immune regulation: FcgammaRIIB-regulating the balance between protective and autoreactive immune responses. Immunology and Cell Biology, 86, 482-484.
16. Bard, F., et al. (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.Nature Medicine, 6, 916-919.
17. Bard, F., et al. (2003). Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's diseaselike neuropathology. Proceedings of the National Academy of Sciences of the United States of America, 100, 2023-2028.
18. Bayry, J., et al. (2007). Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: Rationale and mechanisms of action. Nature Clinical Practice Rheumatology, 3, 262-272.
19. Beard, C. M., et al. (1998). Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: A case-control study in Rochester, Minnesota, 1980 through 1984. Mayo Clinic Proceedings, 73, 951-955.
20. Bernstein, J. J., et al. (1993). Sequestering of immunoglobulins by astrocytes after cortical lesion and homografting of fetal cortex.International Journal of Developmental Neuroscience, 11, 117-124.
21. Bracke, M., et al. (1998). Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. Journal of Immunology, 161, 6768-6774.
22. Brauweiler, A. M., & Cambier, J. C. (2003). Fc gamma RIIB activation leads to inhibition of signalling by independently ligated receptors.Biochemical Society Transactions, 31, 281-285.
23. Breckwoldt, M. O., et al. (2008). Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase.Proceedings of the National Academy of Sciences of the United States of America, 105, 18584-18589.
24. Bruhns, P., et al. (2000). Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB. The Journal of Biological Chemistry, 275, 37357-37364.
25. Chen, S., et al. (1998). Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Archives of Neurology, 55, 1075-1080.
26. Coggeshall, K. M. (2002). Regulation of signal transduction by the Fc gamma receptor family members and their involvement in autoimmunity. Current Directions in Autoimmunity, 5, 1-29.
27. Cote-Vélez, M. J., et al. (1999). Low affinity Fc gamma receptors on murine macrophages: Mitogen-activated protein kinase activation and AP-1 DNA binding activity. Immunology Letters, 67, 251-255.
28. Cox, D., & Greenberg, S. (2001). Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system.Seminars in Immunology, 13, 339-345.
29. Dahlström, A., et al. (1990). Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. Journal of Neural Transmission, 29, 195-206.
30. Das, P., et al. (2003). Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice. Journal of Neuroscience, 23, 8532-8538.
31. Davis, R. S., et al. (2001). Identification of a family of Fc receptor homologs with preferential B cell expression. Proceedings of the National Academy of Sciences of the United States of America, 98, 9772-9777.
32. Davis, R. S., et al. (2002). Fc receptor homologs: Newest members of a remarkably diverse Fc receptor gene family. Immunological Reviews, 190, 123-136.
33. Deane, R., et al. (2005). IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. Journal of Neuroscience, 25, 11495-11503.
34. Deane, R., et al. (2009). Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer's disease. CNS & Neurological Disorders Drug Targets, 8, 16-30.
35. Dessaint, J. P., & Capron, A. (1990). Fc epsilon receptor II-positive macrophages and platelets: Potent effector cells in allergy and defence against helminth parasites. Springer Seminars in Immunopathology, 12, 349-363.
36. Dierks, S. E., et al. (1993). The oligomeric nature of the murine Fc epsilon RII/CD23. Implications for function. Journal of Immunology, 150, 2372-2382.
37. Ebel, C., et al. (2001). Signal transduction via both human lowaffinity IgG Fc receptors, Fc gamma RIIa and Fc gamma RIIIb, depends on the activity of different families of intracellular kinases. Immunobiology, 203, 616-628.
38. Falsig, J., et al. (2008). Molecular basis for detection of invading pathogens in the brain. Journal of Neuroscience Research, 86, 1434-1447.
39. Frangione, B., & Wolfenstein-Todel, C. (1972). Partial duplication in the ''hinge'' region of IgA 1 myeloma proteins. Proceedings of the National Academy of Sciences of the United States of America, 69, 3673-3676.
40. Galon, J., et al. (1996). Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. Journal of Immunology, 157, 1184-1192.
41. Goldstein, B., et al. (2002). Modeling the early signaling events mediated by FcepsilonRI. Molecular Immunology, 38, 1213-1219.
42. Gould, H. J., & Sutton, B. J. (2008). IgE in allergy and asthma today.Nature Reviews Immunology, 8, 205-217.
43. Grant, J. A., et al. (1997). High-affinity IgE receptor Fc epsilon RI expression in allergic reactions. International Archives of Allergy and Immunology, 113, 376-378.
44. Gu, H., et al. (2001). Essential role for Gab2 in the allergic response.Nature, 412, 186-190.
45. Haberman, F., et al. (2007). Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice. Neuromolecular Medicine, 9, 315-323.
46. He, Y., et al. (2002). Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Experimental Neurology, 176, 322-327.
47. Heyman, B. (2000). Regulation of antibody responses via antibodies, complement, and Fc receptors. Annual Review of Immunology, 18, 709-737.
48. Hill, J. M., et al. (1985). Transferrin receptors in rat brain: Neuropeptide-like pattern and relationship to iron distribution.Proceedings of the National Academy of Sciences of the United States of America, 82, 4553-4557.
49. Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in Parkinson's disease: A target for neuroprotection? Lancet Neurology, 8, 382-397.
50. Holtzman, D. M., et al. (2002). Abeta immunization and anti-Abeta antibodies: Potential therapies for the prevention and treatment of Alzheimer's disease. Advanced Drug Delivery Reviews, 54, 1603-1613.
51. Huang, Z. Y., et al. (2003). The effect of phosphatases SHP-1 and SHIP- 1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA. Journal of Leukocyte Biology, 73, 823-829.
52. Hulse, K. E., & Woodfolk, J. A. (2008). Targeting allergen to Fc gammaRI: A strategy to treat allergic disease? Current Opinion in Allergy and Clinical Immunology, 8, 547-552.
53. Hunot, S., et al. (1999). FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide andtumor necrosis factor-alpha in glial cells. Journal of Neuroscience, 19, 3440-3447.
54. Ishikawa, M., et al. (2005). CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion.Circulation, 111, 1690-1696.
55. Ivashkiv, L. B. (2009). Cross-regulation of signaling by ITAMassociated receptors. Nature Immunology, 10, 340-347.
56. Jabril-Cuenod, B., et al. (1996). Sykdependent phosphorylation of Shc: A potential link between FcepsilonRI and the Ras/mitogenactivated protein kinase signaling pathway through SOS and Grb2. The Journal of Biological Chemistry, 271, 16268-16272.
57. Jakus, Z., et al. (2009). Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. Journal of Experimental Medicine, 206, 577-593.
58. Jin, C. Y., et al. (2006). Piceatannol attenuates lipopolysaccharideinduced NF-kappaB activation and NF-kappaB-related proinflammatory mediators in BV2 microglia. Pharmacological Research, 54, 461-467.
59. Johnson, S. A., et al. (1995). Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases. Journal of Immunology, 155, 4596-4603.
60. Johnson, S., et al. (1996). Perforant path transection induces complement C9 deposition in hippocampus. Experimental Neurology, 138, 198-205.
61. Joshi, T., et al. (2006). Molecular analysis of expression and function of hFcgammaRIIbl and b2 isoforms in myeloid cells. Molecular Immunology, 43, 839-850.
62. Kaur, C., & Ling, E. A. (1999). Increased expression of transferrin receptors and iron in amoeboid microglial cells in postnatal rats following an exposure to hypoxia. Neuroscience Letters, 262, 183-186.
63. Kimata, H. (2007). Specific allergen enhances IgE production via galectin-3 in surface IgE? B cells. European Journal of Clinical Investigation, 37, 1001-1002.
64. Kitaura, J., et al. (2000). Akt-dependent cytokine production in mast cells. Journal of Experimental Medicine, 192, 729-740.
65. Komine-Kobayashi, M., et al. (2004). Dual role of Fcgamma receptor in transient focal cerebral ischemia in mice. Stroke, 35, 958-963.
66. Kopeć, A., Panaszek, B., & Fal, A. M. (2006). Intracellular signaling pathways in IgE-dependent mast cell activation. Archivum Immunologiae et Therapiae Experimentalis, 54, 393-401.
67. Lakshmi Tamma, S. M., et al. (2001). IgD receptor-mediated signal transduction in T cells. Cellular Immunology, 207, 110-117.
68. Lalancette-Hébert, M., et al. (2007). Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.Journal of Neuroscience, 27, 2596-2605.
69. Lang, M. L., & Kerr, M. A. (2000). Characterization of FcalphaRtriggered Ca(2?) signals: Role in neutrophil NADPH oxidase activation. Biochemical and Biophysical Research Communications, 276, 749-755.
70. Le, W. D., et al. (1995). Experimental autoimmune nigral damage in guinea pigs. Journal of Neuroimmunology, 57, 45-53.
71. Le, W. D., et al. (1999). Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Archives of Neurology, 56, 194-200.
72. Lees, A. J., et al. (2009). Parkinson's disease. Lancet, 373, 2055-2066
73. Levites, Y., et al. (2006). Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.FASEB Journal, 20, 2576-2578.
74. Li, Y. N., et al. (2008). Alterations of Fc gamma receptor I and Tolllike receptor 4 mediate the antiinflammatory actions of microglia and astrocytes after adrenaline-induced blood-brain barrier opening in rats. Journal of Neuroscience Research, 86, 3556-3565.
75. Liesz, A., et al. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine, 15, 192-199.
76. Loughlin, A. J., et al. (1992). Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: Effects on interferon-gamma induced activation.Immunology, 75, 170-175.
77. Loughlin, A. J., et al. (1993). Modulation of interferon-gammainduced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids.Immunology, 79, 125-130.
78. Love, S. (1999). Oxidative stress in brain ischemia. Brain Pathology, 9, 119-131.
79. Lyden, T. W., et al. (2001). The Fc receptor for IgG expressed in the villus endothelium of human placenta is Fc gamma RIIb2.Journal of Immunology, 166, 3882-3889.
80. Ma, Y., et al. (2006). Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis.Journal of Cell Biology, 175, 209-215.
81. Malbec, O., et al. (2002). Negative regulation of mast cell proliferation by FcgammaRIIB. Molecular Immunology, 38, 1295-1299.
82. Manetz, T. S., et al. (2001). Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells. Molecular and Cellular Biology, 21, 3763-3774.
83. Mangin, P., et al. (2003). Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA. The Journal of Biological Chemistry, 278, 32880-32891.
84. Mash, D. C., et al. (1990). Characterization and distribution of transferrin receptors in the rat brain. Journal of Neurochemistry, 55, 1972-1979.
85. Mattson, M. P. (2004). Pathways towards and away from Alzheimer's disease. Nature, 430, 631-639.
86. McGeer, P. L., et al. (2006). Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years. Journal of Alzheimer's Disease, 9, 271-276.
87. McRae-Degueurce, A., et al. (1988). Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases. Neurochemical Research, 13, 679-684.
88. Mélik-Parsadaniantz, S., & Rostène, W. (2008). Chemokines and neuromodulation. Journal of Neuroimmunology, 198, 62-68.
89. Merrill, J. E., et al. (1980a). A T lymphocyte subpopulation in multiple sclerosis patients bearing Fc receptors for both IgG and IgM1. Journal of Immunology, 124, 2758-2764.
90. Merrill, J. E., et al. (1980b). Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients. Clinical and Experimental Immunology, 42, 345-354.
91. Mina-Osorio, P., & Ortega, E. (2004). Signal regulators in FcRmediated activation of leukocytes? Trends in Immunology, 25, 529-535.
92. Minskoff, S. A., et al. (1998). Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens. Journal of Immunology, 161, 2079-2083.
93. Mohamed, H. A., et al. (2002). Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons.Journal of Neuroscience Research, 69, 110-116.
94. Monteiro, R. C., & Van De Winkel, J. G. (2003). IgA Fc receptors.Annual Review of Immunology, 21, 177-204.
95. Moos, T., et al. (1999). Iron-independent neuronal expression of transferrin receptor mRNA in the rat. Brain Research. Developmental Brain Research, 72, 231-234.
96. Moura, I. C., et al. (2001). Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. Journal of Experimental Medicine, 194, 417-425.
97. Mukhopadhyay, S., et al. (2001). Bruton's tyrosine kinase associates with the actin-based cytoskeleton in activated platelets. Journal of Cellular Biochemistry, 81, 659-665.
98. Muraille, E., et al. (2000). The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosinebased inhibition motif of Fc gammaRIIB in B cells under negative signaling. Immunology Letters, 72, 7-15.
99. Nakahara, J., & Aiso, S. (2006). Fc receptor-positive cells in remyelinating multiple sclerosis lesions. Journal of Neuropathology and Experimental Neurology, 65, 582-591.
100. Nakahara, J., et al. (2003a). Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation.Developmental Cell, 4, 841-852.
101. Nakahara, J., et al. (2003b). Expression of Fc receptor for immunoglobulin M in oligodendrocytes and myelin of mouse central nervous system. Neuroscience Letters, 337, 73-76.
102. Nakamura, T., et al. (1993). Characterization of an IgM Fc-binding receptor on human T cells. Journal of Immunology, 151, 6933-6941.
103. Nakamura, K., et al. (2007). CD3 and immunoglobulin G Fc receptor regulate cerebellar functions. Molecular and Cellular Biology, 27, 5128-5134.
104. Nimmerjahn, F., & Ravetch, J. V. (2008). Fcgamma receptors as regulators of immune responses. Nature Reviews Immunology, 8, 34-47.
105. Nimmerjahn, F., et al. (2005). FcgammaRIV: A novel FcR with distinct IgG subclass specificity. Immunity, 23, 41-51.
106. Ninomiya, N., et al. (1994). Involvement of phosphatidylinositol 3-kinase in Fc gamma receptor signaling. The Journal of Biological Chemistry, 269, 22732-22737.
107. Nishizumi, H., & Yamamoto, Y. (1997). Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. Journal of Immunology, 158, 2350-2355.
108. Nitta, T., et al. (1992). Expression of Fc gamma receptors on astroglial cell lines and their role in the central nervous system.Neurosurgery, 31, 83-87.
109. Ohno, T., et al. (1990). Biochemical nature of an Fc mu receptor on human B-lineage cells. Journal of Experimental Medicine, 172, 1165-1175.
110. Okun, E., et al. (2009). Toll-like receptors in neurodegeneration.Brain Research Reviews, 59, 278-292.
111. Olivera, A., et al. (2006). IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. The Journal of Biological Chemistry, 281, 2515-2525.
112. Orita, T., et al. (1990). Transferrin receptors in injured brain. Acta Neuropathologica, 79, 686-688.
113. Orr, C. F., et al. (2005). A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain, 128, 2665-2674.
114. Ouadrhiri, Y., et al. (2002). Effect of IgA on respiratory burst and cytokine release by human alveolar macrophages: Role of ERK1/2 mitogen-activated protein kinases and NF-kappaB. American Journal of Respiratory Cell and Molecular Biology, 26, 315-332.
115. Pardridge, W. M., et al. (1987). Human blood-brain barrier transferrin receptor. Metabolism, 36, 892-895.
116. Park, R. K., et al. (1999). Role of Src in the modulation of multiple adaptor proteins in FcalphaRI oxidant signaling. Blood, 94, 2112-2120.
117. Peress, N. S., et al. (1993). Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. Journal of Neuroimmunology, 48, 71-79.
118. Perry, V. H., et al. (1985). Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience, 15, 313-326.
119. Rakover, I., et al. (2007). Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels. Neurodegenerative Diseases, 4, 392-402.
120. Ravetch, J. V., & Bolland, S. (2001). IgG Fc receptors. Annual Review of Immunology, 19, 275-290.
121. Ravetch, J. V., et al. (2001). Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 291, 484-486.
122. Renedo, M. A., et al. (2001). FcgammaRIIA exogenously expressed in HeLa cells activates the mitogen-activated protein kinase cascade by a mechanism dependent on the endogenous expression of the protein tyrosine kinase Syk. European Journal of Immunology, 31, 1361-1369.
123. Rivera, J., et al. (2008). New insights on mast cell activation via the high affinity receptor for IgE. Advances in Immunology, 98, 85-120.
124. Robbie-Ryan, M., et al. (2003). Cutting edge: Both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. Journal of Immunology, 170, 1630-1634.
125. Roccatello, D., Quattrocchio, G., Cacace, G., Coppo, R., Sena, L. M., et al. (1993). Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.Laboratory Investigation, 69, 714-723.
126. Roopenian, D. C., & Akilesh, S. (2007). FcRn: The neonatal Fc receptor comes of age. Nature Reviews Immunology, 7, 715-725.
127. Rose, D. M., et al. (1997). Interferon-gamma and transforming growth factor-beta modulate the activation of mitogen-activated protein kinases and tumor necrosis factor-alpha production induced by Fc gamma-receptor stimulation in murine macrophages. Biochemical and Biophysical Research Communications, 238, 256-260.
128. Sada, K., & Yamamura, H. (2003). Protein-tyrosine kinases and adaptor proteins in FcepsilonRI-mediated signaling in mast cells.Current Molecular Medicine, 3, 85-94.
129. Scali, C. (2000). Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: Implication in Alzheimer's disease. European Journal of Neuroscience, 12, 1900-1912.
130. Seiwa, C., et al. (2007). Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. Journal of Neuroscience Research, 85, 954-966.
131. Shichita, T., et al. (2009). Pivotal role of cerebral interleukin-17- producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nature Medicine, 15, 946-950.
132. Sibéril, S., et al. (2006). Molecular aspects of human FcgammaR interactions with IgG: Functional and therapeutic consequences.Immunology Letters, 106, 111-118.
133. Song, X., et al. (2002). Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. Infection and Immunity, 70, 5177-5184.
134. Song, X., et al. (2004). Fcgamma receptor signaling in primary human microglia: Differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine induction. Journal of Leukocyte Biology, 75, 1147-1155.
135. Stevens, B., et al. (2007). The classical complement cascade mediates CNS synapse elimination. Cell, 131, 1164-1178.
136. Stockert, R. J. (1995). The asialoglycoprotein receptor: Relationships between structure, function, and expression. Physiological Reviews, 75, 591-609.
137. Suzuki, T., et al. (2000). Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. Journal of Immunology, 165, 473-482.
138. Takai, T., et al. (2003). Fc receptors as potential targets for the treatment of allergy, autoimmune disease and cancer. Current Drug Targets. Immune, Endocrine and Metabolic Disorders, 3, 187-197.
139. Tang, S. C., et al. (2007). Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Sciences of the United States of America, 104, 13798-13803.
140. Tang, S. C., et al. (2008). Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal. Experimental Neurology, 213, 114-121.
141. Tarasenko, T., et al. (2007). FcgammaRIIB as a modulator of autoimmune disease susceptibility. Autoimmunity, 40, 409-417.
142. Ting, A. T., et al. (1995). Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells. The Journal of Biological Chemistry, 270, 16415-16421.
143. Tkaczyk, C., et al. (2003). The phospholipase C gamma 1-dependent pathway of Fc epsilon RI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. The Journal of Biological Chemistry, 278, 48474-48484.
144. Turner, H., & Kinet, J. P. (1999). Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature, 402, B24-B30.
145. Ueyama, T., et al. (2004). Superoxide production at phagosomal cup/ phagosome through beta I protein kinase C during Fc gamma Rmediated phagocytosis in microglia. Journal of Immunology, 173, 4582-4589.
146. Ulvestad, E., et al. (1994). Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. Journal of the Neurological Sciences, 121, 125-131.
147. Underhill, D. M., & Goodridge, H. S. (2007). The many faces of ITAMs. Trends in Immunology, 28, 66-73.
148. Urich, E., et al. (2006). Autoantibody-mediated demyelination depends on complement activation but not activatory Fcreceptors.Proceedings of the National Academy of Sciences of the United States of America, 103, 18697-18702.
149. Urtz, N., et al. (2004). Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase. Molecular and Cellular Biology, 24, 8765-8777.
150. Van den Herik-Oudijk, I. E., et al. (1995). Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms. Blood, 85, 2202-2211.
151. Vedeler, C., et al. (1994). Fc receptor for IgG (FcR) on rat microglia.Journal of Neuroimmunology, 49, 19-24.
152. Wang, H. H., et al. (2009). Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNKdependent AP-1 pathway in brain astrocytes. Glia, 57, 24-38.
153. Wilcock, D. M., & Colton, C. A. (2009). Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice. CNS & Neurological Disorders Drug Targets, 8, 50-64.
154. Wilcock, D. M., Gordon, M. N., Morgan, D., et al. (2003).Intracranially administered anti-Abeta antibodies reduce betaamyloid deposition by mechanisms both independent of and associated with microglial activation. Journal of Neuroscience, 23, 3745-3751.
155. Williams, M. R., et al. (2000). The role of 3-phosphoinositidedependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Current Biology, 10, 439-448.
156. Wines, B. D., & Hogarth, P. M. (2006). IgA receptors in health and disease. Tissue Antigens, 68, 103-114.
157. Woodroofe, M. N., et al. (1989). Fc receptor density, MHC antigen expression and superoxide production are increased in interferon- gamma-treated microglia isolated from adult rat brain.Immunology, 68, 421-426.
158. Wurzburg, B. A., et al. (2006). Structural changes in the lectin domain of CD23, the low-affinity IgE receptor, upon calcium binding.Structure, 14, 1049-1058.
159. Yenari, M. A., et al. (2006). Microglia potentiate damage to blood- brain barrier constituents: Improvement by minocycline in vivo and in vitro. Stroke, 37, 1087-1093.
160. Yilmaz, G., et al. (2006). Role of T lymphocytes and interferongamma in ischemic stroke. Circulation, 113, 2105-2112.
161. Yoo, E. M., & Morrison, S. L. (2005). IgA: An immune glycoprotein.Clinical Immunology, 116, 3-10.
162. Yu, M., et al. (2006). Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI. Journal of Immunology, 176, 2421-2429.